In April 2005, the FDA approved the first GLP1 analogue, exenatide (Byetta ... and side-effect profile. Liraglutide, an acylated GLP1 analogue that requires daily dosing, is another incretin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback